Related Experiment Video
Updated: Aug 9, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival
Antonio Chiappa1, Andrew P Zbar, Emilio Bertani
1Department of General Surgery, European Institute of Oncology, University of Milano, Milan, Italy. antonio.chiappa@unimi.it
Journal of Surgical Oncology
|April 15, 2006
Summary
An aggressive surgical approach for retroperitoneal sarcoma (RPS) improves survival. Complete resection is key, with high tumor grade negatively impacting outcomes for patients with primary or recurrent RPS.
Area of Science:
- Surgical Oncology
- Sarcoma Research
- Oncology
Background:
- Retroperitoneal sarcoma (RPS) is a rare malignancy.
- Treatment and survival data for RPS are limited.
Purpose of the Study:
- To analyze treatment outcomes and survival rates.
- To evaluate the impact of surgical resection on patients with primary or recurrent RPS.
Main Methods:
- Retrospective analysis of 34 patients (15 male, 19 female) with RPS.
- Defined complete resection as gross tumor removal with clear margins.
- Surgical exploration and resection were performed between 1994 and 2001.
Main Results:
- 82% of patients underwent surgical exploration; 23 achieved complete resection.
- High tumor grade significantly correlated with worse survival (0% vs. 100% at 5 years).
- For completely resected patients, histologic grade and blood transfusions impacted disease-free survival.
Conclusions:
- Aggressive surgical management of RPS, both primary and recurrent, is associated with long-term survival.
- Complete resection is a critical factor for favorable outcomes in RPS treatment.
